CARD Antibodies

Santa Cruz Biotechnology features a diverse variety of CARD Antibodies for advanced research in cellular signaling and immune response. CARD Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CARD proteins, or caspase recruitment domain proteins, play a crucial role in the regulation of apoptosis and inflammation, acting as key mediators in the immune system's response to pathogens. The involvement of CARD proteins in signaling pathways makes them essential for understanding disease mechanisms, particularly in cancer and autoimmune disorders. Research focused on CARD proteins can reveal important therapeutic targets and potential interventions. Understanding CARD protein function is vital for developing new treatment strategies in various diseases. The relationship between CARD proteins and inflammation continues to be an active area of investigation in immunology research. CARD protein studies have contributed significantly to our knowledge of cellular death pathways and immune system regulation. Santa Cruz Biotechnology monoclonal antibodies for CARD proteins enable researchers worldwide to advance scientific understanding of immune system function and disease mechanisms.